Overall, in this study, we revealed that Smad4 phosphorylation by BCR-ABL1 plays an essential role in CML, which adds a novel mechanism to explain how TGF-β signaling is dysregulated in leukemia. This evidence concerns the gene TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive.